Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 6, 1998, Pages 649-656

  Xue, YiXue ^a   Arita, Jiro ^a   Aye, Nu Nu ^a   Hashimoto, Keitaro ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

A 2545; Dog; Flecainide; Mexiletine; Programmed electrical stimulation; Ventricular arrhythmia

Indexed keywords

ADRENALIN; DIGITALIS; FLECAINIDE; MEXILETINE; N3 (2,2,5,5 TETRAMETHYL 3 PYRROLINYL 3 CARBOXAMIDO)PROPYLPHTHALIMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOG; DRUG BLOOD LEVEL; ELECTROSTIMULATION; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; NONHUMAN; REENTRY ARRHYTHMIA;

EID: 0031700658     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005307     Document Type: Article

References (30)

1. Awaji T, Wu ZJ, Hashimoto K (1995) Acute antiarrhythmic effects of intravenously administered amiodarone on canine ventricular arrhythmia. J Cardiovasc Pharmacol 26:869-878
2. Bazett HC (1918) An analysis of the time relations of electrocardiogram. Heart 7:353-370
3. Chen JG, Xue YX, Eto K, Ni C, Hashimoto K (1996) Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs. J Cardiovasc Pharmacol 28:576-584
4. Dunnett C (1963) New table for multiple comparisons with a control. Biometrics 19:482-491
5. El-Sherif N, Mehra R, Gough WB, Zeiler RH (1982) Ventricular activation patterns of spontaneous and induced ventricular rhythms in canine one-day-old myocardial infarction: evidence for focal and reentrant mechanisms. Circ Res 51:152-166
6. Friedman PL, Stewart JR, Wit AL (1973) Spontaneous and induced cardiac arrhythmias in subendocardial Purkinje fibers surviving extensive myocardial infarction in dogs. Circ Res 33:612-626
7. Hankovszky OH, Hideg K, Bodi I, Frank L (1986) New antiarrhythmic agents. 2,2,5,5-tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamides. J Med Chem 29:1138-1152
8. Haruno A, Hashimoto K (1993) Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia. Eur J Pharmacol 233:1-6
9. Hashimoto K, Hashimoto K (1972) The mechanism of sensitization of the ventricle to epinephrine by halothane. Am Heart J 83:652-658
10. Hashimoto K, Ishii M, Komori S (1984) Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias. J Cardiovasc Pharmacol 6:213-219
11. Hashimoto K, Ishii M, Komori S, Mitsuhashi H (1985) Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone. tocanide and SUN 1165. Heart Vessels 1:29-35
12. Hashimoto K, Haruno A, Matsuzaki T, Sugiyama A, Akiyama K (1991a) Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc Drugs Ther 5:805-818
13. Hashimoto K, Haruno A, Matsuzaki T, Hirasawa A, Awaji T, Uemura Y (1991b) Effects of a new class III antiarrhythmic drug (E-4031) on canine ventricular arrhythmia models. Asia Pac J Pharmacol 6:127-137
14. Katoh H, Ogawa S, Furuno I, Sato Y, Yoh S, Saeki K, Nakumura Y (1990) Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model. J Pharmacol Exp Ther 253:1077-1082
15. Kidwell GA, Gonzalez MD (1993) Effects of flecainide and d-sotalol on myocardial conduction and refractoriness: relation to antiarrhythmic and proarrhythmic drug effects. J Cardiovasc Pharmacol 21:621-632
16. Kondoh K, Hashimoto H, Nishiyama H, Umemura K, Ozaki T, Uematsu T, Nakashima M (1994) Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model. J Cardiovasc Pharmacol 23:674-680
17. Kou WH, Nelson SD, Lynch JJ, Montgomery DG, DiCarlo L, Lucchesi BR (1987) Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. J Am Coll Cardiol 9:359-365
18. Lazzara R, El-Sherif N, Scherlag BJ (1973) Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction. Circ Res 33:722-734
19. Le Marec H, Dangman KH, Danilo P Jr, Rosen MR (1985) An evaluation of automaticity and triggered activity in the canine heart one to four days after myocardial infarction. Circulation 71:1224-1236
20. Le Marec H, Spinelli W, Rosen MR (1986) The effects of doxorubicin on ventricular tachycardia. Circulation 74:881-889
21. Lynch JJ, DiCarlo LA, Montgomery DG, Lucchesi BR (1987) Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. Pharmacology 35:181-193
22. 2+ channel blocker, in models of ventricular arrhythmia in dogs. Eur J Pharmacol 231:363-370
23. Miyazaki T, Ogawa S, Sakai T, Hosokawa M, Sakurai K, Nakamura Y (1988) Effects of class I drugs on reentrant ventricular tachycardia in a canine model of myocardial infarction: on their antiarrhythmic and proarrhythmic mechanisms. Jpn Circ J 52:254-261
24. Ogawa S, Mitamura H, Katoh H (1993) Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias in comparison with conventional class I drugs. Cardiovasc Drugs Ther 7 [Suppl 3]:621-626
25. Restivo M, Yin H, Caref EB, Patel AI, Ndrepepa G, Avitable MJ, Assadi MA, Isber N, El-Sherif N (1995) Reentrant arrhythmias in the subacute infarction period: the proarrhythmic effect of flecainide acetate on functional reentrant circuits. Circulation 91:1236-1246
26. Roden DM (1996) Antiarrhythmic drugs. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman Gilman A (eds) Goodman and Gilman's the pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York, pp 839-874
27. Wit AL, Rosen MR (1992) Afterdepolarizations and triggered activity: distinction from automaticity as an arrhythmogenic mechanism. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE (eds) The heart and cardiovascular system, 2nd edn. Raven Press, New York, pp 2113-2163
28. Wu ZJ, Awaji T, Hirasawa A, Motomura S, Hashimoto K (1993) Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models. Mol Cell Biochem 119:159-169
29. Xue YX, Eto K, Akie Y, Hashimoto K (1996) Antiarrhythmic and proarrhythmic effects of sematilide in canine ventricular arrhythmia models. Jpn J Pharmacol 70:129-138
30. Xue Y, Tanabe S, Nabuchi Y, Hashimoto K (1998) Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models. J Cardiovasc Pharmacol 32:239-247